<DOC>
	<DOCNO>NCT02218294</DOCNO>
	<brief_summary>The purpose study assess extent radioactive dose BCX4161 take mouth end urine , feces expire air . If metabolite BCX4161 make body , chemical composition metabolite profile time blood urine determine .</brief_summary>
	<brief_title>Study Determine How BCX4161 Metabolized Eliminated Body</brief_title>
	<detailed_description />
	<mesh_term>Angioedema</mesh_term>
	<mesh_term>Angioedemas , Hereditary</mesh_term>
	<criteria>1 . Healthy male 2 . Age 30 65 year age ( inclusive ) 3 . Body mass index 18.0 32.0 kg/m2 4 . Must willing able communicate participate whole study 5 . Must provide write informed consent 6 . A history regular bowel movement 7 . Must agree use adequate method contraception Key 1 . Participation clinical research study within previous 3 month 2 . Current history drug alcohol abuse past 2 year positive drug abuse screen 3 . Current smoker 4 . Radiation exposure , include present study , exceed 5 mSv last 12 month 10 mSv last 5 year 5 . Clinically significant medical history , current medical psychiatric condition , ECG finding , laboratory/urinalysis abnormality 6 . Activated partial thromboplastin time PT outside normal laboratory limit</criteria>
	<gender>Male</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>BCX4161</keyword>
	<keyword>BioCryst</keyword>
	<keyword>hereditary angioedema</keyword>
	<keyword>mass balance</keyword>
	<keyword>kallikrein inhibitor</keyword>
	<keyword>ADME</keyword>
</DOC>